UICC CEO Cary Adams gives his insights into the challenges of getting cancer treatment to people in low- and middle-income countries.

Growth, expansion, and acquisitions in Germany are on the menu for this global testing and safety company – here’s why

Leaders at Artios explore the potential of expanding therapeutic opportunities in DDR beyond synthetic lethality

Applied correctly, data can do almost anything

Anti-vaccine activists are suing a number of prominent media outlets, including Reuters, the Washington Post, the BBC, and the Associated Press.

It’s a fact that the pharma industry is dominated by white men. What does this mean for people from different ethnic backgrounds?

From video games to climate change; looking back on a handful of articles from 2022.

MIT scientists believe the future is bright for antibiotics discovery

Who do we blame for the return of polio?

In the face of war and the economic fallout of COVID-19, Europe is weathering an energy price storm. What does this mean for medicine makers?